ask="9.95"
ask_size="100"
average_daily_volume="164724"
bid="4.15"
bid_size="100"
book_value="0.00"
change="-0.20"
change_from_200_day_moving_average="6.08"
change_from_50_day_moving_average="4.34"
change_from_52_week_high="-5.58"
change_From_52_week_low="2.12"
change_in_percent="-2.38%"
close="8.22"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="8.49"
high_52_weeks="13.80"
last_trade_date="1/3/2017"
last_trade_price="8.22"
last_trade_size="611"
last_trade_time="4:00pm"
low="8.03"
low_52_weeks="6.10"
market_capitalization="761.62B"
moving_average_200_day="2.14"
moving_average_50_day="3.88"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="8.39"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+283.69%"
percent_change_from_50_day_moving_average="+112.04%"
percent_change_from_52_week_high="-40.43%"
percent_change_from_52_week_low="+34.75%"
previous_close="8.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="92654000000"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="126361"
weeks_range_52="6.10 - 13.80"
